Evonik Industries AG is a publicly-listed German specialty chemicals company headquartered in Essen, North Rhine-Westphalia, Germany.

Its specialty chemicals business generates around 80% of sales in areas where it holds leading market positions.

[6] The company's partnership Deutsche Gasrusswerke (DGW) employed Jewish slave laborers at Gleiwitz concentration camp, a subcamp of Auschwitz.

[13] The IPO, by now planned for fall of 2011, was once again postponed in September 2011, this time citing the "current state of financial and capital markets and their prospects.

"[14] RAG Foundation had planned for Evonik's IPO to take place in 2012, but this was postponed as a result of poor market conditions.

This shortage in turn led to concerns for global production of finished goods, particularly in the automotive industry.

[18] Evonik divested its former holdings in the areas of energy and real estate and now focuses on the core business of specialty chemicals.

It includes six business units: Advanced Intermediates, Consumer Specialties, Coatings & Additives, Inorganic Materials, Health & Nutrition and Performance Polymers.

Its latest acquisition is the Tippecanoe Labs plant site at Lafayette, Indiana from Eli Lilly on 1 January 2010.

[24] In June 2014, the Supervisory Board resolved to restructure the Group, with plans for the six chemical segments to be bundled into three GmbH (limited liability) companies from 2015.

[26] In December 2010, Evonik Industries signed an agreement to sell 51% of shares in its energy business to a consortium of municipal utilities in Germany's Rhine-Ruhr region.